trending Market Intelligence /marketintelligence/en/news-insights/trending/iSnAr740yWuNW46TycDF4g2 content esgSubNav
In This List

2 FluoroPharma directors resign

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


2 FluoroPharma directors resign

Peter Conti and Johan Spoor agreed to resign as directors of FluoroPharma Medical Inc., effective Jan. 1, 2017.

The resignations are not due to any disagreements on any matter relating to the company's operations, policies and practices.